Mengual Lourdes, Olivan Mireia
Laboratory and Department of Urology, Centre de Recerca Biomèdica CELLEX, Hospital Clínic, Universitat de Barcelona, IDIBAPS, C/Casanova, 143, Barcelona, 08036, Barcelona, España.
Group of Biomedical Research in Urology, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
Methods Mol Biol. 2018;1655:227-237. doi: 10.1007/978-1-4939-7234-0_17.
Urine is emerging as a biological fluid suitable to perform liquid biopsy in a minimally invasive manner, a fundamental attribute for prevention and early detection of cancer. Urine biomarkers can be analyzed in voided urine, in urine sediment, and urine supernatant. In the case of urothelial carcinoma, in which tumor cells are in direct contact with urine, the assessment of the levels of biomarkers in the urinary cell fraction appears to be the most promising approach to identify diagnostic and prognostic biomarkers in a noninvasive way. Here, we describe a protocol to collect and process urine samples to obtain urinary exfoliated cells. Furthermore, we describe the methodology to isolate RNA from urinary cells and to quantify gene expression levels from these urinary cells.
尿液正成为一种适合以微创方式进行液体活检的生物流体,这是癌症预防和早期检测的一项基本特性。尿液生物标志物可在排尿、尿沉渣和尿上清液中进行分析。在肿瘤细胞与尿液直接接触的尿路上皮癌病例中,评估尿细胞部分中生物标志物的水平似乎是以非侵入性方式识别诊断和预后生物标志物的最有前景的方法。在此,我们描述了一种收集和处理尿液样本以获得尿脱落细胞的方案。此外,我们还描述了从尿细胞中分离RNA并量化这些尿细胞基因表达水平的方法。